$NBIX 3 SEC Filings

Filed On	Filing
07 Oct 2026	Form 3: Roberts Eiry, Chief Medical Officer Holds 51,331 shares of Common Stock
17 Mar 2026	Form 3: Ratz Andrew, Chief Technical Operations Off Holds 1,018 shares of Common Stock
04 Jun 2025	Form 3: Keswani Sanjay Chandru, Chief Medical Officer No securities owned
13 Jul 2023	Form 3: Poon Christine A, Director No securities owned
15 Feb 2023	Form 3: Delaet Ingrid, Chief Regulatory Officer Holds 3,382 shares of Common Stock
09 Feb 2022	Form 3: Boyer David W., Chief Corp. Affairs Officer Holds 2,075 shares of Common Stock
01 Dec 2021	Form 3: Onyia Jude, Chief Scientific Officer No securities owned
16 Apr 2021	Form 3: Mercier Johanna, Director No securities owned
04 Feb 2020	Form 3: Sharp Shalini, Director No securities owned
12 Sep 2019	Form 3: Norwalk Leslie V, Director No securities owned
17 May 2019	Form 3: Cooke Julie, Chief Human Resources Officer Holds 1,916 shares of Common Stock
14 Mar 2019	Form 3: Neurocrine Biosciences Inc, 10% owner · Voyager Therapeutics Inc No securities owned
10 Jan 2018	Form 3: Roberts Eiry, Chief Medical Officer No securities owned
05 Dec 2017	Form 3: Abernethy Matt, Chief Financial Officer No securities owned
09 Jan 2017	Form 3: Gros David-Alexandre C, President & COO No securities owned
01 Oct 2015	Form 3: Morrow George J, Director No securities owned
04 Sep 2015	Form 3: Sandrock Alfred, Director No securities owned
01 Jun 2015	Form 3: Benevich Eric, Chief Commerical Officer No securities owned
04 Nov 2014	Form 3: Lippoldt Darin, Chief Legal Officer Holds 0 shares of Common Stock
01 Oct 2014	Form 3: Lloyd-Smith Malcolm, Chief Regulatory Officer Holds 0 shares of Common Stock

Comments